{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T14:07:20Z","timestamp":1795183640387,"version":"4.10.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Foundation of the Capital Institute of Pediatrics","award":["QN-2016-09"],"award-info":[{"award-number":["QN-2016-09"]}]},{"name":"Research Foundation of the Capital Institute of Pediatrics","award":["PY-2020-05"],"award-info":[{"award-number":["PY-2020-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Group A streptococcus (GAS) is an important human pathogen responsible for a broad range of infections. Epidemiological surveillance has been crucial to detect changes in the geographical and temporal variation of the disease pattern. The objective of this study was to investigate the molecular epidemiological characteristics and antimicrobial resistance of GAS isolates from patients in Children\u2019s Hospital in Beijing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      From 2016 to 2017, pharyngeal swab samples were collected from the outpatients in Children\u2019s Hospital, Capital Institute of Pediatrics, who were diagnosed with scarlet fever. Antimicrobial susceptibility test was performed according to the distribution of conventional antibiotics and Clinical and Laboratory Standards Institute (CLSI) recommendations. The distribution of the macrolide-resistance genes (\n                      <jats:italic>ermB, ermA, mefA<\/jats:italic>\n                      ),\n                      <jats:italic>emm<\/jats:italic>\n                      (M protein-coding gene) typing, and superantigens (SAg) gene profiling were examined by polymerase chain reaction (PCR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 297 GAS isolates were collected. The susceptibility of the isolates to penicillin, ceftriaxone, and levofloxacin was 100%. The resistance rate to erythromycin and clindamycin was 98.3 and 96.6%, respectively. The dominant\n                      <jats:italic>emm<\/jats:italic>\n                      types were\n                      <jats:italic>emm12<\/jats:italic>\n                      (65.32%),\n                      <jats:italic>emm1<\/jats:italic>\n                      (27.61%),\n                      <jats:italic>emm75<\/jats:italic>\n                      (2.69%), and\n                      <jats:italic>emm89<\/jats:italic>\n                      (1.35%). Of the 297 isolates, 290 (97.64%) carried the\n                      <jats:italic>ermB<\/jats:italic>\n                      gene, and 5 (1.68%) carried the\n                      <jats:italic>mefA<\/jats:italic>\n                      gene, while none carried the\n                      <jats:italic>ermA<\/jats:italic>\n                      gene. The most common superantigen genes identified from GAS isolates were\n                      <jats:italic>smeZ<\/jats:italic>\n                      (96.97%)\n                      <jats:italic>, speC<\/jats:italic>\n                      (92.59%),\n                      <jats:italic>speG<\/jats:italic>\n                      (91.58%),\n                      <jats:italic>ssa<\/jats:italic>\n                      (85.52%),\n                      <jats:italic>speI<\/jats:italic>\n                      (54.55%),\n                      <jats:italic>speH<\/jats:italic>\n                      (52.19%), and\n                      <jats:italic>speA<\/jats:italic>\n                      (34.34%). Isolates with the genotype\n                      <jats:italic>emm1<\/jats:italic>\n                      possessed\n                      <jats:italic>speA<\/jats:italic>\n                      ,\n                      <jats:italic>speC<\/jats:italic>\n                      ,\n                      <jats:italic>speG<\/jats:italic>\n                      ,\n                      <jats:italic>speJ<\/jats:italic>\n                      ,\n                      <jats:italic>speM<\/jats:italic>\n                      ,\n                      <jats:italic>ssa<\/jats:italic>\n                      , and\n                      <jats:italic>smeZ<\/jats:italic>\n                      , while\n                      <jats:italic>emm12<\/jats:italic>\n                      possessed\n                      <jats:italic>speC<\/jats:italic>\n                      ,\n                      <jats:italic>speG<\/jats:italic>\n                      ,\n                      <jats:italic>speH<\/jats:italic>\n                      ,\n                      <jats:italic>speI<\/jats:italic>\n                      ,\n                      <jats:italic>speM<\/jats:italic>\n                      ,\n                      <jats:italic>ssa<\/jats:italic>\n                      , and\n                      <jats:italic>smeZ<\/jats:italic>\n                      superantigens.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The prevalent strain of GAS isolates in Beijing has a high resistance rate to macrolides; however, penicillin can still be the preferred antibiotic for treatment. Erythromycin resistance was predominantly mediated by\n                      <jats:italic>ermB.<\/jats:italic>\n                      The common\n                      <jats:italic>emm<\/jats:italic>\n                      types were\n                      <jats:italic>emm12<\/jats:italic>\n                      and\n                      <jats:italic>emm1.<\/jats:italic>\n                      There was a correlation between\n                      <jats:italic>emm<\/jats:italic>\n                      and the superantigen gene. Thus, long-term monitoring and investigation of the\n                      <jats:italic>emm<\/jats:italic>\n                      types and superantigen genes of GAS prevalence are imperative.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05241-x","type":"journal-article","created":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T08:06:02Z","timestamp":1594627562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9377-722X","authenticated-orcid":false,"given":"Hongxin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"issue":"7","key":"5241_CR1","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1128\/JCM.00301-15","volume":"53","author":"F Koutouzi","year":"2015","unstructured":"Koutouzi F, Tsakris A, Chatzichristou P, Koutouzis E, Daikos GL, Kirikou E, Petropoulou N, Syriopoulou V, Michos A. Streptococcus pyogenes emm types and clusters during a 7-year period (2007 to 2013) in pharyngeal and nonpharyngeal pediatric isolates. J Clin Microbiol. 2015;53(7):2015\u201321.","journal-title":"J Clin Microbiol"},{"issue":"11","key":"5241_CR2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","volume":"5","author":"JR Carapetis","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group a streptococcal diseases. Lancet Infect Dis. 2005;5(11):685\u201394.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"5241_CR3","volume":"10","author":"PX Zheng","year":"2015","unstructured":"Zheng PX, Chan YC, Chiou CS, Chiang-Ni C, Wang SY, Tsai PJ, Chuang WJ, Lin YS, Liu CC, Wu JJ. Clustered regularly interspaced short palindromic repeats are emm type-specific in highly prevalent group a streptococci. PLoS One. 2015;10(12):e0145223.","journal-title":"PLoS One"},{"issue":"1","key":"5241_CR4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12879-016-1775-9","volume":"16","author":"S Wu","year":"2016","unstructured":"Wu S, Peng X, Yang Z, Ma C, Zhang D, Wang Q, Yang P. Estimated burden of group a streptococcal pharyngitis among children in Beijing, China. BMC Infect Dis. 2016;16(1):452.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"5241_CR5","first-page":"877","volume":"26","author":"YH You","year":"2013","unstructured":"You YH, Song YY, Yan XM, Wang HB, Zhang MH, Tao XX, Li LL, Zhang YX, Jiang XH, Zhang BH, et al. Molecular epidemiological characteristics of Streptococcus pyogenes strains involved in an outbreak of scarlet fever in China, 2011. Biomed Environ Sci. 2013;26(11):877\u201385.","journal-title":"Biomed Environ Sci"},{"issue":"3","key":"5241_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/infdis\/jis362","volume":"206","author":"H Tse","year":"2012","unstructured":"Tse H, Bao JY, Davies MR, Maamary P, Tsoi HW, Tong AH, Ho TC, Lin CH, Gillen CM, Barnett TC, et al. Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. J Infect Dis. 2012;206(3):341\u201351.","journal-title":"J Infect Dis"},{"issue":"1","key":"5241_CR7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.50.1.256-261.2006","volume":"50","author":"IN Grivea","year":"2006","unstructured":"Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother. 2006;50(1):256\u201361.","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"5241_CR8","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3855\/jidc.9132","volume":"11","author":"T Abraham","year":"2017","unstructured":"Abraham T, Sistla S. Molecular epidemiology of macrolide resistant group a streptococci from Puducherry, India. J Infect Dev Ctries. 2017;11(9):679\u201383.","journal-title":"J Infect Dev Ctries"},{"issue":"11","key":"5241_CR9","first-page":"1010","volume":"41","author":"HX Li","year":"2019","unstructured":"Li HX, Zhou L, Xu J, Cao HN, Zhang HL, Ma YC, Liu XY, Hu J. Application of group a streptococcal antigen detection and drug sensitivity analysis. Bei Jing Yi Xue. 2019;41(11):1010\u20132.","journal-title":"Bei Jing Yi Xue"},{"issue":"14","key":"5241_CR10","first-page":"2048","volume":"24","author":"JH Cui","year":"2014","unstructured":"Cui JH, Miao Y, Hu XF, Jin B, Ji YL, Li D. Genotyping of emm gene in group a hemolytic streptococcus from children in Xicheng district of Beijing from 2011 to 2013. Chin J Health Lab Tec. 2014;24(14):2048\u201350.","journal-title":"Chin J Health Lab Tec"},{"key":"5241_CR11","first-page":"29","volume":"368","author":"DJ McMillan","year":"2013","unstructured":"McMillan DJ, Sanderson-Smith ML, Smeesters PR, Sriprakash KS. Molecular markers for the study of streptococcal epidemiology. Curr Top Microbiol Immunol. 2013;368:29\u201348.","journal-title":"Curr Top Microbiol Immunol"},{"key":"5241_CR12","doi-asserted-by":"crossref","unstructured":"Bessen DE, Smeesters PR, Beall BW: Molecular Epidemiology, Ecology, and Evolution of Group A Streptococci. Microbiol Spectr 2018, 6(5).","DOI":"10.1128\/microbiolspec.CPP3-0009-2018"},{"issue":"5","key":"5241_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijantimicag.2011.01.019","volume":"37","author":"C Bley","year":"2011","unstructured":"Bley C, van der Linden M. Reinert RR: mef(a) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Int J Antimicrob Agents. 2011;37(5):425\u201331.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"5241_CR14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180757","volume":"12","author":"M Imohl","year":"2017","unstructured":"Imohl M, Fitzner C, Perniciaro S, van der Linden M. Epidemiology and distribution of 10 superantigens among invasive Streptococcus pyogenes disease in Germany from 2009 to 2014. PLoS One. 2017;12(7):e0180757.","journal-title":"PLoS One"},{"key":"5241_CR15","doi-asserted-by":"crossref","unstructured":"Shannon BA, McCormick JK, Schlievert PM: Toxins and Superantigens of Group A Streptococci. Microbiol Spectr 2019, 7(1).","DOI":"10.1128\/microbiolspec.GPP3-0054-2018"},{"issue":"Pt 8","key":"5241_CR16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1099\/jmm.0.46243-0","volume":"55","author":"HB Jing","year":"2006","unstructured":"Jing HB, Ning BA, Hao HJ, Zheng YL, Chang D, Jiang W, Jiang YQ. Epidemiological analysis of group a streptococci recovered from patients in China. J Med Microbiol. 2006;55(Pt 8):1101\u20137.","journal-title":"J Med Microbiol"},{"issue":"Pt 7","key":"5241_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.042309-0","volume":"61","author":"Y Liang","year":"2012","unstructured":"Liang Y, Liu X, Chang H, Ji L, Huang G, Fu Z, Zheng Y, Wang L, Li C, Shen Y, et al. Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children. J Med Microbiol. 2012;61(Pt 7):975\u201383.","journal-title":"J Med Microbiol"},{"key":"5241_CR18","volume-title":"Performance standards for antimicrobial susceptibility testing: clinical and laboratory standards institute (CLSI), M100","author":"CLSI","year":"2018","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing: clinical and laboratory standards institute (CLSI), M100. 28th ed; 2018.","edition":"28"},{"issue":"4","key":"5241_CR19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/AAC.01054-06","volume":"51","author":"E Perez-Trallero","year":"2007","unstructured":"Perez-Trallero E, Montes M, Orden B, Tamayo E, Garcia-Arenzana JM, Marimon JM. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother. 2007;51(4):1228\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"5241_CR20","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/JCM.43.8.4083-4091.2005","volume":"43","author":"NM Green","year":"2005","unstructured":"Green NM, Beres SB, Graviss EA, Allison JE, McGeer AJ, Vuopio-Varkila J, LeFebvre RB, Musser JM. Genetic diversity among type emm28 group a Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol. 2005;43(8):4083\u201391.","journal-title":"J Clin Microbiol"},{"key":"5241_CR21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ebiom.2018.01.010","volume":"28","author":"Y You","year":"2018","unstructured":"You Y, Davies MR, Protani M, McIntyre L, Walker MJ, Zhang J. Scarlet fever epidemic in China caused by Streptococcus pyogenes serotype M12: epidemiologic and molecular analysis. EBioMedicine. 2018;28:128\u201335.","journal-title":"EBioMedicine"},{"issue":"2","key":"5241_CR22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1473-3099(17)30693-X","volume":"18","author":"T Lamagni","year":"2018","unstructured":"Lamagni T, Guy R, Chand M, Henderson KL, Chalker V, Lewis J, Saliba V, Elliot AJ, Smith GE, Rushton S, et al. Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study. Lancet Infect Dis. 2018;18(2):180\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5241_CR23","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1473-3099(18)30231-7","volume":"18","author":"Y Liu","year":"2018","unstructured":"Liu Y, Chan TC, Yap LW, Luo Y, Xu W, Qin S, Zhao N, Yu Z, Geng X, Liu SL. Resurgence of scarlet fever in China: a 13-year population-based surveillance study. Lancet Infect Dis. 2018;18(8):903\u201312.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"5241_CR24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000001442","volume":"36","author":"GP DeMuri","year":"2017","unstructured":"DeMuri GP, Sterkel AK, Kubica PA, Duster MN, Reed KD, Wald ER. Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis. Pediatr Infect Dis J. 2017;36(3):342\u20134.","journal-title":"Pediatr Infect Dis J"},{"key":"5241_CR25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fmicb.2017.01052","volume":"8","author":"B Lu","year":"2017","unstructured":"Lu B, Fang Y, Fan Y, Chen X, Wang J, Zeng J, Li Y, Zhang Z, Huang L, Li H, et al. High prevalence of macrolide-resistance and molecular characterization of Streptococcus pyogenes isolates circulating in China from 2009 to 2016. Front Microbiol. 2017;8:1052.","journal-title":"Front Microbiol"},{"issue":"15","key":"5241_CR26","first-page":"2623","volume":"25","author":"CJ Zhao","year":"2015","unstructured":"Zhao CJ, Peng XM, Yang P, Shi WX, Lu GL, Pang Y. Research on the drug sensitivity test results of group a Streptococcus in children in Beijing in 2013. Chinese Journal of Health Laboratory Technology. 2015;25(15):2623\u20135.","journal-title":"Chinese Journal of Health Laboratory Technology"},{"issue":"2","key":"5241_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/ijmm.IJMM_18_107","volume":"36","author":"T Abraham","year":"2018","unstructured":"Abraham T, Sistla S. Trends in antimicrobial resistance patterns of group a streptococci, molecular basis and implications. Indian J Med Microbiol. 2018;36(2):186\u201391.","journal-title":"Indian J Med Microbiol"},{"issue":"7","key":"5241_CR28","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1590\/0074-0276140231","volume":"109","author":"GP Areas","year":"2014","unstructured":"Areas GP, Schuab RB, Neves FP, Barros RR. Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil. Mem Inst Oswaldo Cruz. 2014;109(7):935\u20139.","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"5241_CR29","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmii.2013.08.015","volume":"48","author":"PK Chuang","year":"2015","unstructured":"Chuang PK, Wang SM, Lin HC, Cho YH, Ma YJ, Ho TS, Shen CF, Liu CC. The trend of macrolide resistance and emm types of group a streptococci from children at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2015;48(2):160\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"5241_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7883\/yoken.JJID.2008.261","volume":"61","author":"EH Koh","year":"2008","unstructured":"Koh EH, Kim S, Lee NY. Decrease of erythromycin resistance in group a streptococci by change of emm distribution. Jpn J Infect Dis. 2008;61(4):261\u20133.","journal-title":"Jpn J Infect Dis"},{"issue":"1","key":"5241_CR31","doi-asserted-by":"crossref","first-page":"18051","DOI":"10.1038\/s41598-019-54409-2","volume":"9","author":"A Friaes","year":"2019","unstructured":"Friaes A, Melo-Cristino J, Ramirez M. Changes in emm types and superantigen gene content of Streptococcus pyogenes causing invasive infections in Portugal. Sci Rep. 2019;9(1):18051.","journal-title":"Sci Rep"},{"key":"5241_CR32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpubh.2018.00059","volume":"6","author":"G Gherardi","year":"2018","unstructured":"Gherardi G, Vitali LA, Creti R. Prevalent emm types among invasive GAS in Europe and North America since year 2000. Front Public Health. 2018;6:59.","journal-title":"Front Public Health"},{"issue":"6","key":"5241_CR33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jmii.2011.07.003","volume":"44","author":"YC Hsieh","year":"2011","unstructured":"Hsieh YC, Huang YC. Scarlet fever outbreak in Hong Kong, 2011. J Microbiol Immunol Infect. 2011;44(6):409\u201311.","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"5241_CR34","first-page":"782","volume":"26","author":"HB Wang","year":"2013","unstructured":"Wang HB, Song YY, You YH, Wang HW, Han QH, Zhao JH, Zhang XX. Molecular epidemiological analysis of group a streptococci isolated from children in Chaoyang District of Beijing, 2011: emm types, virulence factor genes and erythromycin resistant genes. Biomed Environ Sci. 2013;26(9):782\u20134.","journal-title":"Biomed Environ Sci"},{"issue":"22","key":"5241_CR35","first-page":"1700","volume":"25","author":"YM Liang","year":"2010","unstructured":"Liang YM, Chang HS, Shen XZ, Yu SJ, Yuan L, Yang YH. Relationship between emm typing and Superantigen genes speA and speC of Streptococcus Pyogenes isolated from children in Beijing. Journal of Applied Clinical Pediatrics. 2010;25(22):1700\u20132.","journal-title":"Journal of Applied Clinical Pediatrics"},{"issue":"11","key":"5241_CR36","first-page":"917","volume":"30","author":"DT Zhang","year":"2015","unstructured":"Zhang DT, Yang P, Wu SS, Zhao JC, Lu GL, Guo J, Wang QY, Peng XM. M protein gene of group a streptococcus isolated from children with pharyngeal infection in Beijing, 2011-2014. Disease Surveillance. 2015;30(11):917\u201321.","journal-title":"Disease Surveillance"},{"issue":"10","key":"5241_CR37","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1017\/S0950268809002118","volume":"137","author":"Y Ma","year":"2009","unstructured":"Ma Y, Yang Y, Huang M, Wang Y, Chen Y, Deng L, Yu S, Deng Q, Zhang H, Wang C, et al. Characterization of emm types and superantigens of Streptococcus pyogenes isolates from children during two sampling periods. Epidemiol Infect. 2009;137(10):1414\u20139.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"5241_CR38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1473-3099(19)30694-2","volume":"20","author":"Y You","year":"2020","unstructured":"You Y, Peng X, Yang P, Wang Q, Zhang J. 8-year M type surveillance of Streptococcus pyogenes in China. Lancet Infect Dis. 2020;20(1):24\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"5241_CR39","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s10096-015-2462-2","volume":"34","author":"PW Smit","year":"2015","unstructured":"Smit PW, Lindholm L, Lyytikainen O, Jalava J, Patari-Sampo A, Vuopio J. Epidemiology and emm types of invasive group a streptococcal infections in Finland, 2008-2013. Eur J Clin Microbiol Infect Dis. 2015;34(10):2131\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5241_CR40","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.00747-08","volume":"47","author":"MH Zheng","year":"2009","unstructured":"Zheng MH, Jiao ZQ, Zhang LJ, Yu SJ, Tang GP, Yan XM, He LH, Meng FL, Zhao F, Zhang MJ, et al. Genetic analysis of group a streptococcus isolates recovered during acute glomerulonephritis outbreaks in Guizhou Province of China. J Clin Microbiol. 2009;47(3):715\u201320.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"5241_CR41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jmii.2013.08.011","volume":"47","author":"YM Liu","year":"2014","unstructured":"Liu YM, Zhao JZ, Li BB, Yang JY, Dong XG, Zhang JJ, Cao B. A report on the first outbreak of a single clone group a Streptococcus (emm-type 89) tonsillopharyngitis in China. J Microbiol Immunol Infect. 2014;47(6):542\u20135.","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"5241_CR42","first-page":"435","volume":"79","author":"L Bubba","year":"2019","unstructured":"Bubba L, Bundle N, Kapatai G, Daniel R, Balasegaram S, Anderson C, Chalker V, Lamagni T, Brown C, Ready D, et al. Genomic sequencing of a national emm66 group a streptococci (GAS) outbreak among people who inject drugs and the homeless community in England and Wales, January 2016-may 2017. J Inf Secur. 2019;79(5):435\u201343.","journal-title":"J Inf Secur"},{"key":"5241_CR43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/1471-2180-12-280","volume":"12","author":"A Friaes","year":"2012","unstructured":"Friaes A, Pinto FR, Silva-Costa C, Ramirez M, Melo-Cristino J. Group a streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance. BMC Microbiol. 2012;12:280.","journal-title":"BMC Microbiol"},{"issue":"2","key":"5241_CR44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0972-5229.126076","volume":"18","author":"P Mathur","year":"2014","unstructured":"Mathur P, Bhardwaj N, Gupta G, Punia P, Tak V, John NV, Agrawal D, Misra MC. Outbreak of Streptococcus pyogenes emm type 58 in a high dependency unit of a level-1 trauma center of India. Indian J Crit Care Med. 2014;18(2):77\u201382.","journal-title":"Indian J Crit Care Med"},{"issue":"12","key":"5241_CR45","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s10096-008-0561-z","volume":"27","author":"HC Lin","year":"2008","unstructured":"Lin HC, Wang SM, Lin YL, Lin YS, Wu JJ, Chuang WJ, Lin MT, Liu CC. Group a streptococcal infection caused by emm1 strains among children in southern Taiwan. Eur J Clin Microbiol Infect Dis. 2008;27(12):1253\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Pt 8","key":"5241_CR46","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/jmm.0.46481-0","volume":"55","author":"A Rivera","year":"2006","unstructured":"Rivera A, Rebollo M, Miro E, Mateo M, Navarro F, Gurgui M, Mirelis B, Coll P. Superantigen gene profile, emm type and antibiotic resistance genes among group a streptococcal isolates from Barcelona, Spain. J Med Microbiol. 2006;55(Pt 8):1115\u201323.","journal-title":"J Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05241-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05241-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05241-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T01:09:27Z","timestamp":1696381767000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05241-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5241"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05241-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.22135\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22135\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22135\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.22135\/v2","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,13]]},"assertion":[{"value":"23 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Capital Institute of Pediatrics. Written consent forms were obtained from the participants\u2019 guardians before collecting the pharyngeal swab samples, and the anonymity of the participants was guaranteed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have indicated they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}